Erwan Barre is a Partner (Foreign Lawyer) at RHTLaw Asia and the Co-Head of our Corporate and Capital Markets Practice. He joined RHTLaw Asia in 2015 after practicing for 16 years with Sullivan & Cromwell and Paul Hastings, two leading US law firms, in Paris and New York. Focused on corporate transactions, Erwan has extensive experience representing clients across many industries, with an emphasis in the Technology and Life Science industries. He also has management experience, being a co-founder of Vaximax, a biotech company.
Erwan has been involved in many M&A, joint venture, capital markets and financing projects in Asia, Europe and the US, including several game changing transactions. Most of these deals were cross-border. His transactional expertise is based on leading over 100 deals, representing in the aggregate more than US$20 billion. 15 of his deals exceeded US$ 500 million in value. 60% of his transactions involved TMC (telecommunications, media and communications) and life science companies. He has also represented clients in other industries, including aerospace, real estate, hospitality and energy.
His clients include blue chip names as well as promising start-ups and many leading investment banks.
Erwan has been recognised as a leading practitioner in his field by professional publications, such as Chambers and Legal 500, and he is regularly invited as guest speaker at numerous industry conferences in Asia and in Europe.
Some of the recent events that he spoke at include:
• Financial Times Asia Healthcare & Life Sciences Summit
• Asia Pacific MedTech Forum
• Asia Investor on biotechnologies
Erwan holds an MBA from the Neoma (ESC Reims) Business School in France (1990), a pre-doctoral degree (DEA) in business law from the Pantheon-Sorbonne (Paris I) University (1993), and an LL.M. degree from Columbia University in the US (1996). Erwan has worked in Singapore, Paris, New-York and London.
Erwan is admitted in France (1996) and New York (1998) and registered to practice as a foreign lawyer in Singapore.